TCEAL4 Polyclonal Antibody

Rabbit Anti-TCEAL4 Polyclonal Antibody

Product Specifications

Background

TCEAL4 (transcription elongation factor A like 4) encodes a member of the transcription elongation factor A (SII) -like (TCEAL) gene family. This family is comprised of nuclear phosphoproteins that modulate transcription in a promoter context-dependent manner. Multiple family members are located on the X chromosome. Alternatively splicing results in multiple transcript variants. There is a pseudogene for TCEAL4 on chromosome 13.

CAS Number

9007-83-4

Product Name Alternative

TCEAL4; NPD017; Transcription elongation factor A protein-like 4; TCEA-like protein 4; Transcription elongation factor S-II protein-like 4

Gene ID

79921

Accession Number

Q96EI5

Reactivity

Human

Immunogen

Synthesized peptide derived from the C-terminal region of human TCEAL4 at AA range: 140-220

Clonality

Polyclonal

Tag

Transcription elongation factor A protein-like 4

Applications

IHC, IF, ELISA

Purification Method

The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Concentration

1 mg/ml

Precautions

The product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.

Shipping Conditions

Gel pack with blue ice.

Storage Conditions

Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.

Notes

TCEAL4 Polyclonal Antibody detects endogenous levels of TCEAL4 protein.

Formulation

Liquid solution

Buffer pH

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Applications Notes

Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: IHC 1:100-1:300; ELISA 1:20000; IF 1:50-200